Equazen ® Reaffirms Its Commitment to Uncompromising Quality and Sustainability in Omegas Supplements
SFI Health™EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, highlights today its ongoing commitment to delivering the highest standard of quality for Equazen®, the company’s global science-based food supplement brand designed to nourish, enhance and support the brain’s potential.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625554235/en/
Equazen® continues to set the benchmark for excellence at every step of the value chain
At SFI Health™, quality is more than a requirement—it is a mission. The company is committed to enhancing people’s well-being by developing natural supplements that combine passion for nature-based healthcare, science, state-of-the-art production standards and sustainability, from ingredient sourcing to the final product reaching the patient.
In particular, with over 25 years of trust built across multiple markets, Equazen®'s excellence is built on five core pillars:
- Ingredients Sourcing: Equazen®’s story begins in the sea, with responsibly sourced fish oil rich in essential Omega-3 fatty acids EPA and DHA, paired with cold-pressed evening primrose and borage seeds oils for Omega-6 (GLA). Every ingredient is carefully selected from certified suppliers, processed using validated methods ensuring purity and safety as well as full traceability in compliance with European Pharmacopoeia regulations. Besides, Equazen® suppliers are part of the IFFO, the international marine ingredients organization, promoting responsible sourcing and high-quality manufacturing in the industry of fish oil.
- Manufacturing & Supply Chain: Equazen® is produced under strict GMP standards, with each fish oil batch undergoing rigorous quality testing. All manufacturers adhere to recognized food safety systems, including HACCP and FDA registration. The supply chain is equally controlled—from packaging to transport—to protect product integrity till it reaches consumers. In addition, Equazen®’s suppliers are members of GOED (Global Organization for EPA and DHA Omega-3s), a respected international association setting high ethical and quality standards for the Omega-3 industry.
- Science-backed innovation: Equazen® products feature a unique and carefully balanced combination of essential fatty acids (Omega 3 and Omega 6), designed to support cognitive needs. Since its inception in 1999, Equazen® products’ benefits for the human brain have been proven in over 15 pre-clinical and clinical investigations. In addition, ongoing collaborations with global experts and research institutions further strengthen the scientific foundation.
- Customer focus: Understanding and responding to consumer needs is key to Equazen®’s success. Feedback from parents, healthcare professionals, and consumers shapes product development and ongoing support. The brand also offers personalized guidance and educational resources to optimize usage.
- Sustainability: Equazen® also prioritizes environmental responsibility with sustainable production processes designed to minimize environmental impact. Its fish oil is sourced from regulated, sustainable fisheries and is a by-product of the fishmeal industry—ensuring no additional fish are caught for production. In addition, Equazen® fish oils are certified by Friends of the Sea®, a globally recognized independent body guaranteeing responsible sourcing, full traceability, and environmental stewardship.
“Our mission with Equazen® is to provide natural supplements that parents and caregivers can trust to support cognitive needs and the health of human brain,” said Matthew Brabazon, General Manager at SFI Health™ EMEA. “This is made possible only through ethical sourcing, advanced manufacturing, and robust scientific validation.”
As market demands evolve, Equazen® remains dedicated to pushing quality standards further at every step of the value chain to offer best-in-class solutions for optimal cognitive health. Consumers can trust that every product reflects a passion for health, innovation, and sustainability.
About SFI Health™
SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing.
Guided by the belief in the healing potential of natural products, SFI Health™ combines a rigorous pharma-based approach with the benefits of naturally sourced solutions.
An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa.
SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide.
For more information, go to sfihealth.com or follow us SFI Health on LinkedIn.
About Equazen®
Equazen® is a science-based globally branded food supplement designed and studied to help nourish, enhance, and support the human brain’s potential across all life stages.
Each product of the Equazen® range contains a balanced unique combination of essential fatty acids (Omega-3 and Omega-6), which has been clinically proven for more than 20 years to assist with learning capabilities, concentration and healthy brain development.
Equazen® is available in multiple pharmaceutical formats and sizes to support optimal cognitive functions from infants to teenagers.
Currently marketed in 30 countries globally, Equazen® is widely recommended by healthcare professionals and trusted by families for the last 25 years.
Equazen® aims to advance human health naturally, delivering expertly formulated products that empower individuals to reach their cognitive potential.
For more info visit www.equazen.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250625554235/en/
Contacts
For more information
SFI Health™ EMEA Contact
Elisabetta Bianchi
e-mail address: elisabetta.bianchi@sfihealth.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mercans Unveils Strategic Innovations to Enhance Global Payroll and AI-Powered Client Experience26.6.2025 13:00:00 EEST | Press release
Mercans, a global leader in payroll technology, today announced three significant developments aimed at strengthening its service offerings and enhancing client experiences: the establishment of a Payroll Compliance Center of Excellence (CoE), the integration of HiBob into its technology ecosystem, and the launch of an AI-powered Digital Sales Room (DSR). Establishment of Payroll Compliance Center of Excellence In response to the increasing complexity of global payroll regulations, Mercans has established a dedicated Payroll Compliance Center of Excellence. This center brings together subject-matter experts in labor laws, tax regulations, social security frameworks, and data protection policies across all regions served by Mercans. The center is responsible for developing internal compliance benchmarks, automating statutory updates across the G2N Nova payroll engine, and ensuring clients meet all in-country compliance requirements without disruption. By proactively managing compliance,
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day26.6.2025 13:00:00 EEST | Press release
In a significant showcase for investors, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will announce major advancements to its industry-leading oncology pipeline during today’s investor R&D Day. The event comes at a pivotal moment for the Company, which has more than 40 clinical and commercial stage assets in development, a signal of both scale and ambition. “At BeOne, our mission is simple yet bold: to create the world’s first next-generation oncology company,” said John V. Oyler, Co-Founder, Chairman, and CEO. “What we will unveil demonstrates our progress towards this goal today, and the promise for tomorrow. From our innovative discovery engine to one of the broadest pipelines in oncology, we are well-positioned to bring transformative medicines to patients worldwide—and to do so with speed, quality, and purpose.” BeOne’s integrated, end-to-end R&D model is engineered for efficiency without compromise. The Company’s differentiated approach
Barilla: New Research Shows Eating Pasta Can Lift Your Mood26.6.2025 12:00:00 EEST | Press release
Recent research conducted in Italy by Università Cattolica del Sacro Cuore, with support from Barilla Group, has explored the psychological and emotional effects of pasta consumption. The research team led by Professor Francesco Pagnini, a clinical psychologist with previous academic affiliations at Harvard University, investigates the relationship between pasta consumption and emotional well-being. The findings, published in the journal Food Science & Nutrition, suggest that pasta consumption is associated with increased happiness, reduced stress, and improved quality of life. The study titled "Pasta, what a feeling! A multi-method study on the relationship between pasta consumption and happiness" used an observational design to examine the unique emotional and psychological effect of pasta. Unlike other foods, the study, with a focus on the Italian market, revealed that pasta seems to boost happiness and reduce stress, particularly when enjoyed in social settings like family dinners
ZEDRA Appoints Dean Blackburn as CEO26.6.2025 12:00:00 EEST | Press release
ZEDRA, a global specialist provider of Active Wealth, Corporate & Global Expansion, Funds and Pension & Incentives services, today announces the appointment of Dean Blackburn as Chief Executive Officer. Having joined the business as Deputy Chief Executive Officer in September 2024, Dean has a proven track record in inspiring and motivating teams - fostering a culture of collaboration, and innovation, which has consistently translated into strong business performance and growth. Dean brings more than 25 years of executive leadership experience across the financial and professional services sectors, having previously served as Chief Commercial Officer and Group Head of Institutional Client Services at JTC. Based in Jersey, Dean will work closely with the firm’s senior leaders to ensure the continuation of exceptional service delivery for clients. Speaking to his appointment, Dean commented, “I am thrilled to step into this role at such a pivotal time in our evolution as a business. Havin
HCL Group and UpLink Launch Fourth Global Aquapreneur Innovation Challenge to Boost Water Resilience26.6.2025 11:30:00 EEST | Press release
Global conglomerateHCL Group and UpLink, early-stage innovation initiative of the World Economic Forum, have announced the fourth challenge of the Aquapreneur Innovation Initiative, the Water Resilience Challenge. The announcement was made at the Annual Meeting of the New Champions in Tianjin, China. Applications are open untilAugust 4, 2025, with winners to be announced in January 2026. The top 10 winners will receive a total financial award of CHF1.75 million divided amongst the innovators. For detailed information and eligibility criteria, visit: https://wef.ch/4kTNwHD This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250624538984/en/ John Dutton, Head of UpLink, announcing the launch of Aquapreneur Innovation Initiative Challenge 4 Important Dates to Note 25 June to 4 August 2025 Open for submissions August 2025 Review and selection process January 2026 Announcement of the winners The Aquapreneur Innovation Initiative is a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom